The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

Share Price Information for Aukett Swanke (AUK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.40
Bid: 1.30
Ask: 1.50
Change: -0.15 (-9.68%)
Spread: 0.20 (15.385%)
Open: 1.40
High: 1.40
Low: 1.35
Prev. Close: 1.55
AUK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

8 Dec 2022 12:40

RNS Number : 1046J
Aukett Swanke Group PLC
08 December 2022
 

8 December 2022

 

Aukett Swanke Group Plc

("Aukett Swanke", the "Company", or, together with its subsidiaries, the "Group")

Board Changes

 

Aukett Swanke Group Plc is pleased to announce the following board changes:

 

Group Chief Executive Officer

As announced on 30 March 2022, Nicholas Thompson, who has been a director of the Group for 28 years, of which 17 years have been as Group Chief Executive Officer, will retire as Chief Executive Officer and stand down from the Board on 31 December 2022.

 

From 1 January 2023, Robert Fry, currently an Executive Director on the Board and the Managing Director of the Group's international businesses, will become Chief Executive Officer. Robert has 35 years' experience in the industry, with 17 years at executive level, and has been with the Group for the past nine years.

 

Non-Executive Chairman

The Group is also pleased to announce that Clive Carver, who has been an independent non-executive director since May 2019, has been appointed Independent Non-Executive Chairman with immediate effect. Raul Curiel, who has been Non-Executive Chairman for the past three and a half years will remain on the Board as a non-executive director.

 

For further information please contact: 

Aukett Swanke Group Plc

Nicholas Thompson, Antony Barkwith

+44 (0) 20 7843 3000

 

Strand Hanson Limited (Financial and Nominated Adviser)

James Bellman, Richard Johnson

+44 (0) 20 7409 3494

Arden Partners plc (Broker)

John Llewellyn-Lloyd, Louisa Waddell

+44 (0) 20 7614 5900

Investor/Media

Chris Steele

+44 (0) 7979 604 687

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKFBNBBDDCBK
Date   Source Headline
26th Apr 20243:15 pmRNSResult of Annual General Meeting
26th Apr 20247:55 amRNSAGM Trading Statement
4th Apr 20247:00 amRNSSubscription Update & Director/PDMR Notifications
28th Mar 202411:52 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSFinal Results and Notice of AGM
27th Mar 202412:04 pmRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSAcquisition, Subscription and Notice of Results
19th Feb 20247:00 amRNSArtificial Intelligence Consortium
14th Feb 202410:40 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSCommercial Update
4th Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSLaunch of Employee Share Purchase Plans
17th Nov 20232:32 pmRNSHolding(s) in Company
14th Nov 20239:02 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAcquisition of TR Control Solutions Limited
10th Oct 202311:15 amRNSHolding(s) in Company
5th Oct 202312:01 pmRNSProperty marketed for sale
17th Jul 20237:00 amRNSAcquisition of Anders+Kern U.K. Limited
27th Jun 20237:05 amRNSAppointment of Chief Operating Officer
27th Jun 20237:00 amRNSInterim Results
27th Apr 20231:20 pmRNSHolding(s) in Company
24th Apr 20237:00 amRNSAppointment of Non-Executive Director
21st Apr 202311:45 amRNSResult of AGM and Board Changes
5th Apr 20233:15 pmRNSPosting of Notice of AGM and Annual Report
4th Apr 20237:00 amRNSDisposal of Live Events Business
28th Mar 20237:00 amRNSResults for the year ended 30 September 2022
21st Mar 20237:00 amRNSResult of GM, Board Change, Acquisition Completion
2nd Mar 20237:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
1st Feb 20234:53 pmRNSChange of Adviser
30th Jan 20234:37 pmRNSHolding(s) in Company
8th Dec 202212:40 pmRNSBoard Changes
17th Nov 20229:00 amRNSHolding(s) in Company
5th Oct 20223:15 pmRNSHolding(s) in Company
6th Sep 20227:00 amRNSHolding(s) in Company
2nd Sep 202211:20 amRNSHolding(s) in Company
16th Aug 20227:00 amRNSHolding(s) in Company
4th Aug 20223:27 pmRNSHolding(s) in Company
4th Aug 20223:24 pmRNSHolding(s) in Company
25th Jul 202210:53 amRNSCompletion of Nominated Adviser Due Diligence
29th Jun 20227:00 amRNSInterim Results
7th Jun 20226:00 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSSale of John R Harris & Partners Limited
29th Apr 20227:00 amRNSSale of John R Harris & Partners Limited
28th Apr 20227:00 amRNSAppointment of Nominated Adviser
26th Apr 20227:00 amRNSAnnouncement of results of AGM
11th Apr 20227:00 amRNSHolding(s) in Company
31st Mar 20227:00 amRNSAnnouncement of final results for the year end
28th Feb 20228:45 amRNSHolding(s) in Company
30th Jun 20217:00 amRNSGrant of Options to a director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.